Updated: Oct 11, 2026

Albert Lowe's Stock Ratings

Craig-Hallum Analyst

Albert Lowe is an analyst at Craig-Hallum. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

39.1%

Smart Score

60.8%

Overall Average Return Percentile

90th

Number of Ratings

14
Buy NowGet Alert
09/29/2026RZLTBuy Now
Rezolute
$4.9042.86%$4 → $7UpgradeHold → BuyGet Alert
09/23/2026CMPXBuy Now
Compass Therapeutics
$0.99707.27%$15 → $8MaintainsBuyGet Alert
06/03/2026CRDFBuy Now
Cardiff Oncology
$1.1081.97%$10 → $2DowngradeBuy → HoldGet Alert
04/27/2026SPRBBuy Now
Spruce Biosciences
$44.05217.82% → $140Initiates → BuyGet Alert
12/04/2025PVLABuy Now
Palvella Therapeutics
$138.7726.11% → $175Initiates → BuyGet Alert
06/17/2025NGNEBuy Now
Neurogene
$26.4189.32% → $50Initiates → BuyGet Alert
06/05/2025ATOSBuy Now
Atossa Therapeutics
$2.4066.67% → $4Initiates → BuyGet Alert
04/11/2025IRDBuy Now
Opus Genetics
$4.6728.48% → $6Initiates → BuyGet Alert
03/21/2025SKYEBuy Now
Skye Bioscience
$1.70723.53%$18 → $14MaintainsBuyGet Alert
10/09/2024SABSBuy Now
SAB Biotherapeutics
$2.98269.13% → $11Initiates → BuyGet Alert
09/06/2024CRDFBuy Now
Cardiff Oncology
$1.10627.87% → $8Initiates → BuyGet Alert
08/20/2024LCTXBuy Now
Lineage Cell Therapeutics
$1.03288.35% → $4Initiates → BuyGet Alert
07/09/2024SKYEBuy Now
Skye Bioscience
$1.70958.82% → $18Initiates → BuyGet Alert
05/13/2024PMVPBuy Now
PMV Pharma
$1.57282.17% → $6Initiates → BuyGet Alert